Effects of dynorphin (1-8) on movement: non-opiate effects and structure-activity relationship.
Cell bodies in the head of the caudate nucleus that synthesize prodynorphin peptides form a substantial projection to the substantia nigra pars reticulata (SNR). The discovery of this pathway suggested an involvement of prodynorphin products in motor control. The effects of unilateral nigral microinjections of prodynorphin products were tested in an in vivo circling model. Dynorphin (1-8), dynorphin (1-7), dynorphin (1-6), dynorphin (2-17) (des-Tyr-dynorphin), and Leu-enkephalin induced spontaneous contralateral circling at 20 nmol doses. The effect of dynorphin (1-8) was dose dependent and was not blocked by pretreatment with naloxone or WIN 44,441-3. These findings clearly demonstrate the dynorphinergic involvement in nigral motor control which may consist of an opioid and a non-opioid component.
D000818:Animals; D004399:Dynorphins / Q000031:analogs & derivatives* / Q000494:pharmacology*; D004743:Enkephalin, Leucine / Q000494:pharmacology; D007028:Hypothalamic Hormones / Q000494:pharmacology*; D008297:Male; D009043:Motor Activity / Q000187:drug effects*; D010446:Peptide Fragments / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D013239:Stereotyped Behavior / Q000187:drug effects*; D013329:Structure-Activity Relationship; D013378:Substantia Nigra / Q000187:drug effects / Q000502:physiology
D007028:Hypothalamic Hormones; D010446:Peptide Fragments; D004743:Enkephalin, Leucine; D004399:Dynorphins; C026770:dynorphin (1-8)